Turning Point Therapeutics



TP Therapeutics is a structure-based drug design pharmaceutical company.

Yishan Li
Co-Founder, Director, and Head of Turning Point Therapeutics Asia
Andrew Partridge
EVP, Chief Commercial Officer
Siegfried Reich
EVP, Chief Scientific Officer
Kumar Srinivasan
EVP, Chief Business Officer
Mohammad Hirmand
EVP, Chief Medical Officer
Ed Gemo
SVP, Chief Information Officer
Annette C. North
EVP, General Counsel
Robert Xin
SVP, Clinical Development
Jeffrey P. Whitten
SVP, Pre-Clinical Development
Jim Mazzola
SVP, Communication & Investor Relations
Homa Yeganegi
SVP, Project Team Leader and Head of Medical Affairs
Armin Graber
VP, Companion Diagnostics & Biomarkers
Brion W. Murray
VP, Cancer Biology
Heather Adams
Krishna Allamneni
VP, Development Sciences
Miriam Cruz
VP, Clinical Operations
Naresh K. Nayyar
VP, Regulatory Affairs
Paolo Tombesi

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.